Precision BioSciences (DTIL) Tops Q1 EPS by 17c

Precision BioSciences (NASDAQ: DTIL) reported Q1 EPS of ($0.33), $0.17 better than the analyst estimate of ($0.50). Revenue for the quarter came in at $16.35 million versus the consensus estimate of $7.11 million.

For earnings history and earnings-related data on Precision BioSciences (DTIL) click here.

You May Also Be Interested In

• Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
• Macquarie cuts Macau gaming sector forecasts on weak GGR growth
• BWS Financial Starts Capstone Energy Plus (CEPL) at Buy